The Canopy Growth Corp. in Ontario announced Monday that the Canadian and German governments have given the thumbs up to its wholly owned subsidiary Tweed Inc. to begin exporting medical cannabis for sale to German patients, according to a press release.
Tweed will export its medical cannabis to MedCann GmbH Pharma and Nutraceuticals, a privately held pharmaceutical importer and manufacturer.
Germans are legally allowed to obtain medical cannabis through pharmacies for several medical conditions, but the country has not yet established domestic cannabis production.
Tweed will initially export two strains to Germany, and will expand that number as opportunities arise.
Earlier this year, Canopy announced that it is partnering with companies in Australia and Brazil to bring its products into those markets.
Tweed is not the only Canadian cannabis exporter. Tilray in British Columbia received permission in June to export cannabis to Croatia while PharmaCielo recently received a business permit to manufacture MMJ products in Colombia, which it will be allowed to export to other markets.
